The Cutaneous Lymphoma Foundation offers two Young Investigator Awards each year to new physicians and scientists in the field of cutaneous lymphoma research.
Since 2003, this annual award has been given to support travel to the Society for Investigative Dermatology (SID) Annual Meeting and participation in the concurrent CTCL Symposium. Due to the positive response of the initial award in 2011, we began offering a second award to an investigator presenting at the American Society of Hematology (ASH) Annual Meeting.
Criteria for selection of the Young Investigator Award include:
- Individuals with a MD or PhD degree.
- Individuals with an academic rank no greater than assistant professor.
- Individuals with demonstrable interest and/or achievement in clinical care, education or research in cutaneous lymphomas.
- Individuals who have submitted an abstract and will presenting research at either the ASH or SID annual meeting.
About Our 2018 European Organization for Research and Treatment of Cancer (EORTC) Young Investigator Award Recipient
This is the first year that the Cutaneous Lymphoma Foundation has offered a Young Investigator Award for the researcher presenting at the EORTC Cutaneous Lymphoma Taskforce meeting. We are pleased to announce Stefan M. Schieke, MD, as the recipient of the 2018 EORTC Young Investigator Award for his research focused on functional heterogeneity and metabolic requirements of cancer cells in treatment resistance and progression of cutaneous T-cell lymphoma. Dr. Schieke is an Assistant Professor of Dermatology at the University of Wisconsin-Madison.
2019 Society of Investigative Dermatology Young Investigator Award Recipients
The Cutaneous Lymphoma Foundation was pleased to award two Young Investigator Awards (YIA) for the 2019 Society of Investigative Dermatology (SID) annual meeting. The recipients are Amrita Goyal, MD, from the University of Minnesota, and Shamir Geller, MD, from Memorial Sloan Kettering Cancer Center and the Tel Aviv Medical Center.
Dr. Goyal's research examined the differences between primary cutaneous gamma/delta T-cell lymphoma and subcutaneous panniculitis-like T-cell lymphoma. The results of the study should allow clinicians to build a more accurate differential diagnosis for patients with lymphocytic panniculitis, and more accurately prognosticate clinical outcomes.
Dr. Geller's research focused on the impact of CCR4 expression in CD8+ cutaneous T-cell lymphomas and lymphoproliferative disorders and its implications for diagnosis and treatment.
2018 American Society of Hematology Young Investigator Award Recipient
The Cutaneous Lymphoma Foundation is pleased to announce the recipient of the 2018 Young Investigator Award, Pamela B. Allen, MD, MS. The Award is for travel to present her research at the American Society of Hematology (ASH) annual meeting. Dr. Allen is a clinical investigator in the Division of Hematology and associate professor at the Emory University School of Medicine in Atlanta, GA. Her awarded research was a retrospective analysis in patients with cutaneous T-cell lymphoma to assess whether maintenance therapy, including skin-directed and systemic therapies, following total skin electron beam (TSEB) therapy improved outcomes.